Corona Remedies' Rs 655-cr IPO subscribed 9.33 times on day 2

• Corona Remedies' Rs 655-crore IPO was subscribed 9.33 times on day 2.
• Non-Institutional Investors subscribed 26.80 times, RIIs 6.37 times, and QIBs 1.67 times.
• The company mobilized Rs 195 crore from anchor investors.
• The IPO is an offer for sale (OFS) by promoters and existing investors, concluding on December 10.
• Corona Remedies is a pharma firm specializing in women's healthcare, cardio-diabeto, pain management, and urology.

Why It Matters: Corona Remedies' oversubscribed IPO signals strong market interest.